Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17751-17800 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02367989
Effects of Barley on Glucose Control
NA
Active, not recruiting
24 participants
Started: Nov 8, 2017 · Completed: Jan 31, 2025
1 condition
2 sponsors
1 location
NCT03306927
Effect of Peas in Chili on Blood Glucose and Appetite Control
NA
Active, not recruiting
24 participants
Started: Nov 8, 2017 · Completed: Jan 31, 2025
2 conditions
3 sponsors
1 location
NCT04754035
Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
PHASE2
Active, not recruiting
31 participants
Started: Nov 8, 2017 · Completed: Sep 1, 2025
1 condition
1 sponsor
1 location
NCT03279692
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
PHASE2
Active, not recruiting
26 participants
Started: Nov 7, 2017 · Completed: Dec 31, 2026
1 condition
2 sponsors
2 locations
NCT03301220
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
PHASE3
Active, not recruiting
390 participants
Started: Nov 7, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
163 locations
NCT03306706
Effect of Peas in Muffins on Blood Glucose and Appetite Control
NA
Active, not recruiting
24 participants
Started: Nov 7, 2017 · Completed: Jan 31, 2025
2 conditions
3 sponsors
1 location
NCT03372564
CREST: Capsular Repair During Hip Arthroscopy
NA
Active, not recruiting
250 participants
Started: Nov 7, 2017 · Completed: Dec 31, 2040
1 condition
1 sponsor
3 locations
NCT03164564
Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
PHASE3
Active, not recruiting
3,224 participants
Started: Nov 7, 2017 · Completed: Oct 17, 2026
1 condition
1 sponsor
20 locations
NCT03016338
Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
PHASE2
Active, not recruiting
51 participants
Started: Nov 6, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
7 locations
NCT03214029
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
N/A
Active, not recruiting
2,000 participants
Started: Nov 6, 2017 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05961826
COLPAC (RaDiCo Cohort) (RaDiCo-COLPAC)
N/A
Active, not recruiting
650 participants
Started: Nov 6, 2017 · Completed: Jun 30, 2028
1 condition
1 sponsor
21 locations
NCT03616990
Supportive Release Center Study
NA
Active, not recruiting
15,195 participants
Started: Nov 6, 2017 · Completed: Dec 31, 2025
5 conditions
8 sponsors
1 location
NCT03002389
Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics
PHASE2
Active, not recruiting
95 participants
Started: Nov 5, 2017 · Completed: Jan 31, 2028
1 condition
1 sponsor
1 location
NCT03376152
Rural China Electric Kettle Promotion Program
NA
Active, not recruiting
6,000 participants
Started: Nov 4, 2017 · Completed: Dec 31, 2025
3 conditions
3 sponsors
1 location
NCT03330691
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
PHASE1
Active, not recruiting
78 participants
Started: Nov 3, 2017 · Completed: Mar 3, 2035
2 conditions
1 sponsor
5 locations
NCT03286530
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
PHASE2
Active, not recruiting
64 participants
Started: Nov 3, 2017 · Completed: Dec 31, 2026
3 conditions
5 sponsors
6 locations
NCT03335670
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
EARLY_PHASE1
Active, not recruiting
30 participants
Started: Nov 3, 2017 · Completed: Jun 30, 2030
1 condition
4 sponsors
1 location
NCT03244384
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer
PHASE3
Active, not recruiting
739 participants
Started: Nov 3, 2017 · Completed: Jun 1, 2026
11 conditions
1 sponsor
919 locations
NCT03098459
Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study
N/A
Active, not recruiting
432 participants
Started: Nov 2, 2017 · Completed: Oct 31, 2027
8 conditions
3 sponsors
1 location
NCT03434509
Ongoing Tai Chi Training for Children With ADHD
NA
Active, not recruiting
50 participants
Started: Nov 2, 2017 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT04127214
The ITA Model of Integrated Treatment of Eating Disorders
N/A
Active, not recruiting
800 participants
Started: Nov 2, 2017 · Completed: Oct 31, 2025
6 conditions
2 sponsors
8 locations
NCT03209154
An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment
NA
Active, not recruiting
1,000 participants
Started: Nov 1, 2017 · Completed: Dec 31, 2025
1 condition
5 sponsors
1 location
NCT03338309
INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
N/A
Active, not recruiting
1,200 participants
Started: Nov 1, 2017 · Completed: Dec 1, 2025
5 conditions
3 sponsors
4 locations
NCT04092634
"Dual Mobility in High Risk Patients"
PHASE4
Active, not recruiting
412 participants
Started: Nov 1, 2017 · Completed: Feb 1, 2035
1 condition
4 sponsors
4 locations
NCT03255434
LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy
PHASE2
Active, not recruiting
160 participants
Started: Nov 1, 2017 · Completed: Jul 31, 2025
1 condition
1 sponsor
11 locations
NCT03351907
Cardiovascular Disease Cohort in Guangdong Province
N/A
Active, not recruiting
5,000 participants
Started: Nov 1, 2017 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT03451370
First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer
N/A
Active, not recruiting
121 participants
Started: Nov 1, 2017 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03369977
BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients
NA
Active, not recruiting
202 participants
Started: Nov 1, 2017 · Completed: Nov 30, 2020
1 condition
1 sponsor
7 locations
NCT05953181
Statistical Analysis Plan for the SANO-trial: Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Active Surveillance for Oesophageal Cancer
NA
Active, not recruiting
776 participants
Started: Nov 1, 2017 · Completed: Jun 1, 2026
4 conditions
1 sponsor
1 location
NCT03348969
Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC
PHASE4
Active, not recruiting
120 participants
Started: Nov 1, 2017 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03210662
Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
PHASE2
Active, not recruiting
20 participants
Started: Nov 1, 2017 · Completed: Dec 31, 2026
11 conditions
2 sponsors
1 location
NCT03270917
ORANGE SEGMENTS: Open Versus Laparoscopic Parenchymal Preserving Postero-Superior Liver Segment Resection
NA
Active, not recruiting
250 participants
Started: Nov 1, 2017 · Completed: Nov 1, 2026
1 condition
17 sponsors
16 locations
NCT04324008
Clinical Comparison of Different Flowable Resin Composites
NA
Active, not recruiting
28 participants
Started: Nov 1, 2017 · Completed: Nov 1, 2024
1 condition
1 sponsor
1 location
NCT03333122
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
N/A
Active, not recruiting
575 participants
Started: Oct 31, 2017 · Completed: Jan 31, 2030
1 condition
1 sponsor
1 location
NCT03336333
A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL
PHASE3
Active, not recruiting
590 participants
Started: Oct 31, 2017 · Completed: Sep 30, 2026
2 conditions
1 sponsor
158 locations
NCT03065387
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation
PHASE1
Active, not recruiting
93 participants
Started: Oct 31, 2017 · Completed: Oct 1, 2025
10 conditions
2 sponsors
1 location
NCT03260465
Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup
NA
Active, not recruiting
53 participants
Started: Oct 30, 2017 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT03321539
Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma
PHASE3
Active, not recruiting
216 participants
Started: Oct 30, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT03029884
Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain
NA
Active, not recruiting
4 participants
Started: Oct 28, 2017 · Completed: Jun 30, 2026
4 conditions
3 sponsors
1 location
NCT03299049
Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults
PHASE3
Active, not recruiting
1,049 participants
Started: Oct 27, 2017 · Completed: Dec 31, 2029
1 condition
2 sponsors
118 locations
NCT03310424
Transcriptomic and Next Generation Sequencing Approaches to Infection With Treponema Pallidum
N/A
Active, not recruiting
46 participants
Started: Oct 27, 2017 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT03449914
The GOLD Study: G8 in OLDer Patients
N/A
Active, not recruiting
109 participants
Started: Oct 26, 2017 · Completed: Jul 31, 2024
1 condition
2 sponsors
1 location
NCT03313804
Priming Immunotherapy in Advanced Disease With Radiation
PHASE2
Active, not recruiting
76 participants
Started: Oct 26, 2017 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT03320252
Endurant CHevAr New Indication Trial: ENCHANT
N/A
Active, not recruiting
150 participants
Started: Oct 26, 2017 · Completed: Jul 31, 2030
1 condition
1 sponsor
26 locations
NCT03203473
Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)
PHASE2
Active, not recruiting
85 participants
Started: Oct 26, 2017 · Completed: Dec 28, 2025
1 condition
2 sponsors
8 locations
NCT03227146
Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
PHASE2
Active, not recruiting
14 participants
Started: Oct 25, 2017 · Completed: Aug 31, 2025
1 condition
6 sponsors
6 locations
NCT03218488
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
N/A
Active, not recruiting
135 participants
Started: Oct 25, 2017 · Completed: Aug 31, 2032
1 condition
1 sponsor
30 locations
NCT02636569
Topical Chemoprevention of Skin Cancer Biomarkers
PHASE2
Active, not recruiting
24 participants
Started: Oct 25, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT02879695
Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia
PHASE1
Active, not recruiting
28 participants
Started: Oct 25, 2017 · Completed: Jul 18, 2026
4 conditions
1 sponsor
7 locations
NCT03182244
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
PHASE3
Active, not recruiting
276 participants
Started: Oct 25, 2017 · Completed: Mar 31, 2026
1 condition
1 sponsor
49 locations
Previous
1
More pages
353
354
355
356
357
358
359
More pages
431
Next